Edwards Lifesciences Corporatio

Historical 13F Holders

Symbol
EW
CUSIP
28176E108
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 1,307 524 M $40.7 B
2025 Q2 1,310 506 M $39.5 B
2025 Q1 1,258 499 M $36.2 B
2024 Q4 1,292 502 M $37.2 B
2024 Q3 1,275 491 M $32.4 B
2024 Q2 1,362 508 M $46.8 B
2024 Q1 1,342 509 M $48.6 B
2023 Q4 1,307 500 M $38.2 B
2023 Q3 1,282 494 M $34.2 B
2023 Q2 1,333 496 M $46.8 B
2023 Q1 1,299 498 M $41.2 B
2022 Q4 1,284 535 M $40.5 B
2022 Q3 1,303 518 M $42.8 B
2022 Q2 1,317 511 M $48.6 B
2022 Q1 1,356 511 M $60.0 B
2021 Q4 1,367 517 M $66.9 B
2021 Q3 1,272 514 M $58.2 B
2021 Q2 1,236 514 M $53.2 B
2021 Q1 1,179 510 M $42.6 B
2020 Q4 1,216 531 M $49.2 B
2020 Q3 1,129 516 M $41.2 B
2020 Q2 1,093 509 M $35.2 B
2020 Q1 1,067 172 M $32.3 B
2019 Q4 1,149 177 M $41.2 B
2019 Q3 1,022 174 M $38.1 B
2019 Q2 987 174 M $32.2 B
2019 Q1 979 176 M $33.6 B
2018 Q4 918 180 M $27.6 B
2018 Q3 906 184 M $32.0 B
2018 Q2 882 178 M $25.9 B
2018 Q1 855 175 M $24.4 B
2017 Q4 814 176 M $19.9 B
2017 Q3 772 177 M $19.3 B
2017 Q2 760 176 M $20.8 B
2017 Q1 729 178 M $16.8 B
2016 Q4 732 182 M $17.1 B
2016 Q3 728 180 M $21.7 B
2016 Q2 731 179 M $18.4 B
2016 Q1 699 186 M $16.0 B
2015 Q4 638 185 M $14.8 B
2015 Q3 597 89.3 M $12.7 B
2015 Q2 605 85.2 M $12.1 B
2015 Q1 597 91.1 M $13.0 B
2014 Q4 587 92.8 M $11.8 B
2014 Q3 522 92.4 M $9.47 B
2014 Q2 452 95.3 M $8.18 B
2014 Q1 443 97.7 M $7.25 B